OANEX | QUSIX | OANEX / QUSIX | |
Total Expense Ratio | 1.08 | 1.05 | 103% |
Annual Report Gross Expense Ratio | 1.08 | 1.27 | 85% |
Fund Existence | 9 years | 17 years | - |
Gain YTD | 27.462 | 25.185 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 1000000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.34B | 702M | 191% |
Annual Yield % from dividends | 1.88 | 2.59 | 73% |
Returns for 1 year | 12.15 | 17.39 | 70% |
Returns for 3 years | 76.50 | 68.80 | 111% |
Returns for 5 years | 71.43 | 66.63 | 107% |
Returns for 10 years | N/A | 88.71 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IETC | 103.93 | 1.31 | +1.28% |
iShares U.S. Tech Independence Fcs ETF | |||
VB | 257.98 | 2.25 | +0.88% |
Vanguard Small-Cap ETF | |||
THRO | 38.08 | 0.32 | +0.85% |
iShares U.S. Thematic Rotation ActiveETF | |||
BCIL | 28.91 | 0.07 | +0.24% |
Bancreek International Large Cap ETF | |||
PBE | 72.05 | 0.12 | +0.16% |
Invesco Biotechnology & Genome ETF |